台灣生物科技產業醫療器材類策略態勢與發展方向之分析：以五鼎、百略、及必翔公司為例

本研究是以生技產業醫材類上市上櫃業者中五鼎、百略及必翔公司為研究對象，透過問卷、訪談、及次級資料的取得，利用SPACE矩陣分析法以找出醫材業者之策略態勢，並依據其策略態勢研擬未來策略方向。所獲得的結果是，此三業者在目前財務強勢、競爭優勢、環境穩定性、及產業強勢等四個構面水準均高的情況下，其策略態勢皆處於攻擊態勢；然而仍有競爭壓力高的威脅，及企業規模稍小的劣勢。業者未來策略方向之重點在於(1)善用現有財務強勢及競爭優勢以擴大經營規模，維繫其競爭優勢；(2)持續研發、創新及朝向相關多角化，以增加新進入者的障礙；(3)跨國策略的佈局與整合，以提升全球競爭優勢。文章之後，提出對業者、政府單位及相關業者之建議，以期成為台灣的第二個策略性高科技產業，帶動台灣產業競爭優勢。

關鍵字

生物科技；醫療器材；策略態勢

並列摘要

This study sample is from Apex, Microlife, and Pihsiang in the Public-Listed companies of the medical instrument of biotechnology through questionnaires, interviews and secondary data, and utilize SPACE matrix to analyze their strategy posture. Then draw the future fit strategy according to each company's posture. As a result, the Public-Listed companies of medical instrument show a strong position to the financial strength, competitive advantage, environmental stability and industry strength in the present time, so they all stay under the aggressive posture. How ever, they still have a threat to competitive pressure and weakness to small scale in management. For the future strategy, these medical instrument companies should emphasize (1) making best use of present financial strengths and competitive advantages to enlarge managing scale for sustaining competitive advantages; (2) continuing R & D and innovation to new products, and using related diversification to increase new competitors' barriers; (3) using transnational strategy to design and integrate the global distinctive competency to enhance global competitive advantage. Finally, the study presents some suggestions to medical instrument companies, our government and related industries in order to make medical instrument industry a second strategic High-tech industry to create an advantage in Taiwan industries.